BSE - Delayed Quote INR

Morepen Laboratories Limited (MOREPENLAB.BO)

66.55
-1.32
(-1.94%)
At close: May 23 at 3:54:01 PM GMT+5:30
Loading Chart for MOREPENLAB.BO
  • Previous Close 67.87
  • Open 67.72
  • Bid 66.50 x --
  • Ask --
  • Day's Range 66.21 - 68.05
  • 52 Week Range 41.66 - 100.80
  • Volume 991,167
  • Avg. Volume 652,816
  • Market Cap (intraday) 36.466B
  • Beta (5Y Monthly) 0.96
  • PE Ratio (TTM) 30.25
  • EPS (TTM) 2.20
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 18, 2002
  • 1y Target Est --

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

www.morepen.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: MOREPENLAB.BO

View More

Performance Overview: MOREPENLAB.BO

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

MOREPENLAB.BO
15.01%
S&P BSE SENSEX (^BSESN)
4.58%

1-Year Return

MOREPENLAB.BO
33.74%
S&P BSE SENSEX (^BSESN)
8.36%

3-Year Return

MOREPENLAB.BO
62.71%
S&P BSE SENSEX (^BSESN)
50.53%

5-Year Return

MOREPENLAB.BO
327.97%
S&P BSE SENSEX (^BSESN)
166.43%

Compare To: MOREPENLAB.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MOREPENLAB.BO

View More

Valuation Measures

Annual
As of 5/22/2025
  • Market Cap

    37.19B

  • Enterprise Value

    36.86B

  • Trailing P/E

    30.85

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.01

  • Price/Book (mrq)

    3.22

  • Enterprise Value/Revenue

    2.03

  • Enterprise Value/EBITDA

    19.15

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.45%

  • Return on Assets (ttm)

    6.65%

  • Return on Equity (ttm)

    11.60%

  • Revenue (ttm)

    18.3B

  • Net Income Avi to Common (ttm)

    1.18B

  • Diluted EPS (ttm)

    2.20

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.27B

  • Total Debt/Equity (mrq)

    8.85%

  • Levered Free Cash Flow (ttm)

    -1.9B

Research Analysis: MOREPENLAB.BO

View More

Company Insights: MOREPENLAB.BO

Research Reports: MOREPENLAB.BO

View More

People Also Watch